Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pressurized IntraPeritoneal Aerosol Chemotherapy With Cisplatin and Doxorubicin (PIPAC) in Gastric Peritoneal Metastasis: A Feasibility Study

NCT07517419 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT07517419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07517419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pressurized IntraPeritoneal Aerosol Chemotherapy With Cisplatin and Doxorubicin (PIPAC) in Gastric Peritoneal Metastasis: A Feasibility Study
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
October 11, 2021
Completion date
February 28, 2031
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer peritoneal metastases